SK Chemicals : Decision on Entering into Trust Contract for Acquisition of Treasury Stock
March 23, 2022 at 05:24 am
Share
Decision on Entering into Trust Contract for Acquisition of Treasury Stock
1. Contract amount (KRW)
50,000,000,000
2. Contract period
Start date
2022-03-23
End date
2022-09-22
3. Purpose of contract
Shareholder return policy to enhance shareholder value
4. Counterparty (trust company)
SK Securities Co., Ltd.
5. Scheduled contract date
2022-03-23
6. Treasury stock holdings before contract
Acquisition within profits available for dividends (shrs.)
Common stock
-
Ratio (%)
-
Different classes of stocks
-
Ratio (%)
-
Acquisition for other reasons (shrs.)
Common stock
30,857
Ratio (%)
0.2
Different classes of stocks
148,133
Ratio (%)
0.8
7. Date of board resolution (decision date)
2022-03-21
- Attendance of outside directors
Present (No.)
4
Absent (No.)
-
- Attendance of auditors (members of Audit Committee who are not outside directors)
-
8. Entrusted brokerage company
SK Securities Co., Ltd.
9. Other matters to be factored into investment decisions
- Treasury stocks acquired through this trust contract will be used to enhance shareholder value through retirement, etc. in the future. However, as this is an acquisition through the conclusion of a trust contract, in the case of retirement, etc., the relevant details will be decided and disclosed through a separate board meeting.
【Limit to Acquiring Treasury Stocks】
Category
Amount (KRW)
1. Limit to "profits available for dividends" in the Commercial Act as of the immediately preceding business year end
ⓐ. Net assets
885,073,321,363
ⓑ. Amount of capital
66,000,330,000
ⓒ. Total amount of capital reserve and earned surplus reserves accumulated up to preceding business year
271,311,180,257
ⓓ. Unrealized gain as prescribed by Presidential Decree
90,263,180
Sub total (ⓐ-ⓑ-ⓒ-ⓓ)
547,671,547,926
2. Acquired amount of treasury stock after previous fiscal year end
3,165,774,250
3. Amount of 'dividends' and related 'earned profit reserve' decided at annual general meeting of shareholders after previous fiscal year end
28,765,274,945
4. Amount of 'interim/quarterly dividends' and related 'earned profit reserves' decided by board of directors after previous fiscal year end
64,647,023,980
5. Amount of trust contract
-
6. Acquisition cost of treasury stock sold after previous fiscal year end (moving average method)
-
Limit to acquisition of treasury stock (1-2-3-4-5+6)
451,093,474,751
【Holding Amount of Treasury Stock before Decision to Enter into Trust Contract】
(in shrs.)
Methods of acquisition
Type of stocks
Beginning balance
Change
Closing balance
Remarks
Acquisition (+)
Disposal (-)
Share retirement (-)
Amount of stocks acquired within profits available for dividends
Direct acquisition
Direct acquisition in exchange
Common stock
-
-
-
-
-
-
Different classes of stocks
-
-
-
-
-
-
Direct acquisition in OTC
Common stock
-
-
-
-
-
-
Different classes of stocks
-
-
-
-
-
-
Tender offer
Common stock
-
-
-
-
-
-
Different classes of stocks
-
-
-
-
-
-
Sub total (a)
Common stock
-
-
-
-
-
-
Different classes of stocks
-
-
-
-
-
-
Acquisition by trust contract
Number of stocks indirectly held through trust contracts
Common stock
-
-
-
-
-
-
Different classes of stocks
-
-
-
-
-
-
Number of stocks directly held
Common stock
-
-
-
-
-
-
Different classes of stocks
-
-
-
-
-
-
Sub total (b)
Common stock
-
-
-
-
-
-
Different classes of stocks
-
-
-
-
-
-
Amount of stocks acquired for other reasons (c)
Common stock
30,857
-
-
-
30,857
-
Different classes of stocks
148,133
-
-
-
148,133
-
Total (a+b+c)
Common stock
30,857
-
-
-
30,857
-
Different classes of stocks
148,133
-
-
-
148,133
-
Attachments
Original Link
Original Document
Permalink
Disclaimer
SK Chemicals Co. Ltd. published this content on 23 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 March 2022 05:23:02 UTC.
SK Chemicals Co Ltd is a Korea-based company mainly engaged in the production and sale of chemicals. The Company operates its business through two segments. The Green Chemical segment is engaged in the manufacture and sale of products such as bio copolyester resins, copolyester resins, polyethylene terephthalate (PET) resins, biodiesels, and bio heavy oil. The Life Sciences segment is engaged in the manufacture and sale of medicines, vaccines, and blood products. The Company sells products in domestic and overseas markets such as the United States, Europe, China, Japan, and Singapore.